Travere Therapeutics Appoints Bradley L. Campbell as Chief Executive Officer
Position
Chief Executive Officer
Company
Travere Therapeutics
San DiegoBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Travere Therapeutics announced that Eric Dube, Ph.D., will step down as president and chief executive officer to focus on his health and family. The company has appointed Bradley L. Campbell to succeed him as president and chief executive officer.
Quick answer
Travere Therapeutics Appoints Bradley L. Campbell as Chief Executive Officer (September 21, 2026). Travere Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Executive Officer at Travere Therapeutics?
- Travere Therapeutics named Bradley L. Campbell Chief Executive Officer, announced September 21, 2026.
- What did Travere Therapeutics announce on September 21, 2026?
- Travere Therapeutics announced that Eric Dube, Ph.D., will step down as president and chief executive officer to focus on his health and family. The company has appointed Bradley L. Campbell to succeed him as president and chief executive officer.
- What does Travere Therapeutics do?
- Travere Therapeutics, Inc. is a biotechnology company focused on developing and commercializing innovative therapies for people living with rare diseases.
- Where is Travere Therapeutics based?
- Travere Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Abivax (September 21, 2026), Pharming Group (September 29, 2026), Aquestive Therapeutics, Inc. (September 29, 2026) and Os Therapies (October 1, 2026) also announced leadership changes within 45 days of Travere Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Abivax SA Appoints Chris Rabbat as Chief Marketing Officer and Tim Kelly as Chief Technology Officer (September 21, 2026)
- Pharming Appoints Leverne Marsh and Kenneth Lynard as Interim Co-CEOs (September 29, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Alchemab Therapeutics Appoints Dr Ben Porter-Brown as Chief Medical Officer (September 10, 2026)
Who to call at Travere Therapeutics, and when
A new leader at Travere Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Travere Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Travere Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Travere Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Travere Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Travere Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.